Literature DB >> 25234571

The length of the linker between the epidermal growth factor-like domains in factor VIIa is critical for a productive interaction with tissue factor.

Egon Persson1, Jesper J Madsen, Ole H Olsen.   

Abstract

Formation of the factor VIIa (FVIIa)-tissue factor (TF) complex triggers the blood coagulation cascade. Using a structure-based rationale, we investigated how the length of the linker region between the two epidermal growth factor (EGF)-like domains in FVIIa influences TF binding and the allosteric activity enhancement, as well as the interplay between the γ-carboxyglutamic acid (Gla)-containing and protease domains. Removal of two residues from the native linker was compatible with normal cofactor binding and accompanying stimulation of the enzymatic activity, as was extension by two (Gly-Ser) residues. In sharp contrast, truncation by three or four residues abolished the TF-mediated stabilization of the active conformation of FVIIa and abrogated TF-induced activity enhancement. In addition, FVIIa variants with short linkers associated 80-fold slower with soluble TF (sTF) as compared with wild-type FVIIa, resulting in a corresponding increase in the equilibrium dissociation constant. Molecular modeling suggested that the shortest FVIIa variants would have to be forced into a tense and energetically unfavorable conformation in order to be able to interact productively with TF, explaining our experimental observations. We also found a correlation between linker length and the residual intrinsic enzymatic activity of Ca(2+)-free FVIIa; stepwise truncation resulting in gradually higher activity with des(83-86)-FVIIa reaching the level of Gla-domainless FVIIa. The linker appears to determine the average distance between the negatively charged Gla domain and a structural element in the protease domain, presumably of opposite charge, and proximity has a negative impact on apo-FVIIa activity.
© 2014 The Protein Society.

Entities:  

Keywords:  allostery; factor VIIa; linker region; structural complementarity; tissue factor

Mesh:

Substances:

Year:  2014        PMID: 25234571      PMCID: PMC4253812          DOI: 10.1002/pro.2553

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  35 in total

1.  The connecting segment between both epidermal growth factor-like domains in blood coagulation factor IX contributes to stimulation by factor VIIIa and its isolated A2 domain.

Authors:  Patrick H N Celie; Gunny Van Stempvoort; Caroline Fribourg; Leon J Schurgers; Peter J Lenting; Koen Mertens
Journal:  J Biol Chem       Date:  2002-03-29       Impact factor: 5.157

2.  Scalable molecular dynamics with NAMD.

Authors:  James C Phillips; Rosemary Braun; Wei Wang; James Gumbart; Emad Tajkhorshid; Elizabeth Villa; Christophe Chipot; Robert D Skeel; Laxmikant Kalé; Klaus Schulten
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

3.  Generation of Gla-domainless FVIIa by cathepsin G-mediated cleavage.

Authors:  E M Nicolaisen; L C Petersen; L Thim; J K Jacobsen; M Christensen; U Hedner
Journal:  FEBS Lett       Date:  1992-07-20       Impact factor: 4.124

Review 4.  The molecular basis of blood coagulation.

Authors:  B Furie; B C Furie
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

5.  Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor.

Authors:  Y Z Ohkubo; J H Morrissey; E Tajkhorshid
Journal:  J Thromb Haemost       Date:  2010-02-24       Impact factor: 5.824

6.  Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.

Authors:  Maria Osterlund; Egon Persson; Magdalena Svensson; Uno Carlsson; Per-Ola Freskgård
Journal:  Biochem Biophys Res Commun       Date:  2005-02-18       Impact factor: 3.575

7.  Activation-dependent exposure of the inter-EGF sequence Leu83-Leu88 in factor Xa mediates ligand binding to effector cell protease receptor-1.

Authors:  G Ambrosini; J Plescia; K C Chu; K A High; D C Altieri
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

8.  Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.

Authors:  P O Freskgård; O H Olsen; E Persson
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

9.  Importance of substrate composition, pH and other variables on tissue factor enhancement of factor VIIa activity.

Authors:  P F Neuenschwander; D E Branam; J H Morrissey
Journal:  Thromb Haemost       Date:  1993-12-20       Impact factor: 5.249

10.  Anchored design of protein-protein interfaces.

Authors:  Steven M Lewis; Brian A Kuhlman
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

View more
  4 in total

1.  Allostery in Coagulation Factor VIIa Revealed by Ensemble Refinement of Crystallographic Structures.

Authors:  Anders B Sorensen; Jesper J Madsen; Thomas M Frimurer; Michael T Overgaard; Prafull S Gandhi; Egon Persson; Ole H Olsen
Journal:  Biophys J       Date:  2019-04-02       Impact factor: 4.033

2.  Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.

Authors:  William E Plautz; Vijaya Satish Sekhar Pilli; Brian C Cooley; Rima Chattopadhyay; Pamela R Westmark; Todd Getz; David Paul; Wolfgang Bergmeier; John P Sheehan; Rinku Majumder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-01       Impact factor: 8.311

3.  Conformational Plasticity-Rigidity Axis of the Coagulation Factor VII Zymogen Elucidated by Atomistic Simulations of the N-Terminally Truncated Factor VIIa Protease Domain.

Authors:  Jesper J Madsen; Ole H Olsen
Journal:  Biomolecules       Date:  2021-04-08

Review 4.  Uncovering Membrane-Bound Models of Coagulation Factors by Combined Experimental and Computational Approaches.

Authors:  Y Zenmei Ohkubo; Jesper J Madsen
Journal:  Thromb Haemost       Date:  2021-07-02       Impact factor: 5.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.